Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 04, 2018 08:30 ET | Source: Fluidigm Corporation

Fluidigm Announces Agreement with DNA Software to Offer Secondary CNV Analysis for Biomark HD

SOUTH SAN FRANCISCO, Calif., Oct. 04, 2018 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM) today announced that it has entered into a non-exclusive distribution agreement with DNA Software,...
October 01, 2018 16:15 ET | Source: Fluidigm Corporation

Fluidigm Announces Conference Call and Webcast of Third Quarter 2018 Financial Results

SOUTH SAN FRANCISCO, Calif., Oct. 01, 2018 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), a leader in mass cytometry and microfluidics technologies, announced today that it will report...
September 27, 2018 16:05 ET | Source: Fluidigm Corporation

Fluidigm Introduces Single-Cell Total RNA Sequencing Applications for C1

SOUTH SAN FRANCISCO, Calif., Sept. 27, 2018 (GLOBE NEWSWIRE) -- Fluidigm Corporation, a leader in mass cytometry and microfluidics technologies, today announced two new total RNA sequencing...
September 10, 2018 08:30 ET | Source: Fluidigm Corporation

Fluidigm Announces Co-Marketing Agreement with Visiopharm to Expand and Simplify Imaging Mass Cytometry Data Analysis

SOUTH SAN FRANCISCO, Calif., Sept. 10, 2018 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM) and Visiopharm A/S today announced a co-marketing relationship to automate image analysis for...
September 07, 2018 07:30 ET | Source: Fluidigm Corporation

Fluidigm Partners with GenomOncology to Provide a Comprehensive Immuno-Oncology Gene Expression Solution on Biomark HD

SOUTH SAN FRANCISCO, Calif., Sept. 07, 2018 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM) and GenomOncology today announced an expanded Immuno-Oncology Gene Expression Workflow to...
September 05, 2018 18:00 ET | Source: Fluidigm Corporation

Fluidigm to Participate at Upcoming Investor Events in September

SOUTH SAN FRANCISCO, Calif., Sept. 05, 2018 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ: FLDM), a leader in mass cytometry and microfluidics technologies, announced today that the company’s...
August 09, 2018 08:30 ET | Source: Fluidigm Corporation

Fluidigm to Host 2nd Annual Imaging Mass Cytometry User Group Meeting

SOUTH SAN FRANCISCO, Calif., Aug. 09, 2018 (GLOBE NEWSWIRE) -- Fluidigm Corporation, a leader in mass cytometry and microfluidics technologies, today announced it will hold its 2nd Annual Imaging...
August 06, 2018 16:05 ET | Source: Fluidigm Corporation

Fluidigm Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SOUTH SAN FRANCISCO, Calif., Aug. 06, 2018 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM) today announced that the Compensation Committee of its Board of Directors, which is comprised...
August 02, 2018 16:05 ET | Source: Fluidigm Corporation

Fluidigm Announces Second Quarter 2018 Financial Results

Total revenue increases 11 percent to $26.4 million Mass cytometry revenue growth of 32 percent Total consumables revenue growth of 19 percent SOUTH SAN FRANCISCO, Calif., Aug. 02, 2018 (GLOBE...
July 31, 2018 08:30 ET | Source: Fluidigm Corporation

Fluidigm Introduces a Lower-Cost Workflow for Full-Length Single-Cell mRNA Sequencing on C1

SOUTH SAN FRANCISCO, Calif., July 31, 2018 (GLOBE NEWSWIRE) -- Fluidigm Corporation, a leader in mass cytometry and microfluidics technologies, today announced a new full-length single-cell mRNA...